Zomedica Pharmaceuticals Corp (ZOM) — Cash Flow-to-Debt Ratio
Latest as of March 2025:
-0.63x
Zomedica Pharmaceuticals Corp (ZOM) has a Cash Flow-to-Debt Ratio of -0.63x as of March 2025, meaning its operating cash flow of $-6.65 Million could theoretically repay -1% of its total liabilities ($10.55 Million) in one year. See financial flexibility index of Zomedica Pharmaceuticals Corp to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.63x
Operating CF / Total Liabilities
Operating Cash Flow
$-6.65 Million
USD
Total Liabilities
$10.55 Million
USD
Data as of
Mar 2025
Most recent filing
Zomedica Pharmaceuticals Corp Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Zomedica Pharmaceuticals Corp across 12 annual periods. For the full cash flow conversion analysis, see ZOM cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Zomedica Pharmaceuticals Corp (2013–2024)
Year-by-year debt coverage analysis for Zomedica Pharmaceuticals Corp.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.02x | $-23.63 Million | $11.70 Million | ▼ -66.7% |
| 2023 | -1.21x | $-15.97 Million | $13.18 Million | ▼ -26.9% |
| 2022 | -0.96x | $-11.67 Million | $12.22 Million | ▲ +36.3% |
| 2021 | -1.50x | $-14.28 Million | $9.51 Million | ▼ -39.3% |
| 2020 | -1.08x | $-16.24 Million | $15.08 Million | ▲ +85.6% |
| 2019 | -7.49x | $-15.63 Million | $2.09 Million | ▼ -59.7% |
| 2018 | -4.69x | $-11.15 Million | $2.38 Million | ▲ +45.2% |
| 2017 | -8.56x | $-7.09 Million | $828.74K | ▼ -39.0% |
| 2016 | -6.16x | $-4.56 Million | $741.16K | ▼ -1705.1% |
| 2015 | -0.34x | $-49.88K | $146.29K | ▲ +96.8% |
| 2014 | -10.54x | $-41.44K | $3.93K | ▲ +12.6% |
| 2013 | -12.06x | $-62.19K | $5.16K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.